IPX-233

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIPX-233
Drug Alias NameIPX-233C0002IPX-233C0001IPX-233IPX-233T0001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCentral nervous system stimulants
TargetsNot applicable
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesImpax Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImpax Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with Hyperactivity

Other Information

ATC CodeN/A
Related LinksN/A